Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemoprevention
Gupta, A. K.; Pedroarena, J.; Nazarian, A.; Antonova-Koch, J.; Weiss, F.; Kumpornsin, K.; Chi, V.; Woods, A. K.; Lee, K.-J.; Joseph, S. B.; Li, S.; Brittain, J.; Hostos, E. D.; Duffy, J.; Cooper, A.; Schultz, P. G.; McNamara, C. W.; Chatterjee, A. K.
Show abstract
In efforts towards eliminating malaria, a discovery program was initiated to identify a novel antimalarial using KAF156 as a starting point. Following the most recent TCP/TPP guidelines, we have identified mCMQ069 with a predicted single oral dose for treatment ([~]40-106 mg) and one-month chemoprevention ([~]96-216 mg). We have improved unbound MPC and predicted human clearance by 18-fold and 10-fold respectively when compared to KAF156.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes 97%
- A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease 96%
- Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19 96%
Similar papers in this journal
- Synergistic Cytotoxicity Between Cold Atmospheric Plasma and Pyrazolopyrimidinones Against Glioblastoma Cells 97%
- Exploring thienothiadiazine dioxides as isosteric analogues of benzo- and pyridothiadiazine dioxides in the search of new AMPA and kainate receptor positive allosteric modulators 97%
- Shifting the selectivity of pyridopyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily 96%
Similar papers in this journal
- Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolopyrimidines as Potential Candidates to Treat Human African Trypanosomiasis 95%
- Design and analysis of the 4-anilino-quin(az)oline kinase inhibition profiles of GAK/SLK/STK10 using quantitative structure activity relationships 95%
- Targeting the water network in cyclin G associated kinase (GAK) with 4-anilino-quin(az)oline inhibitors 95%
Similar papers in this journal
- Legacy 4(1H)-quinolone scaffolds activity against acute and chronic Toxoplasma gondii infection 95%
- Mammalian deubiquitinating enzyme inhibitors display in vitro and in vivo activity against malaria parasites and potentiate artemisinin action 94%
- High-throughput screening of more than 30,000 compounds for anthelmintics against gastrointestinal nematode parasites 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.